EP300 and plasma cell myeloma: This screen also revealed multiple myeloma and neuroblastoma cell lines, which show acute dependence on p300/CBP39,45, to be markedly sensitive to CBPD-409 relative to the majority of tested normal and cancer cell lines (Figure 6C).